Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
A substantial proportion of cases with secondary progressive multiple sclerosis have extensive inflammation in the leptomeninges that is associated with increased subpial demyelination, neuronal loss and an exacerbated disease course. However, the mechanisms underlying this extensive subpial pathology are poorly understood. We hypothesize that pro-inflammatory cytokine production within the meninges may be a key to this process. Post-mortem cerebrospinal fluid and dissected cerebral leptomeningeal tissue from patients with multiple sclerosis were used to study the presence of tumour necrosis factor and interferon gamma protein and messenger RNA levels. A novel model of subpial cortical grey matter demyelination was set up in Dark Agouti rats and analysed using quantitative immunohistochemistry. Increased expression of the pro-inflammatory cytokines tumour necrosis factor and interferon gamma was found in the meninges of cases with secondary progressive multiple sclerosis exhibiting tertiary lymphoid-like structures. Injection of tumour necrosis factor and interferon gamma into the subarachnoid space of female Dark Agouti rats pre-immunized with a subclinical dose of myelin oligodendrocyte glycoprotein mimicked the pathology seen in multiple sclerosis, including infiltration of lymphocytes (CD4+ and CD8+ T cells and CD79+ B cells) into the meninges and extensive subpial demyelination. Extensive microglial/macrophage activation was present in a gradient from the pial surface to deeper cortical layers. Demyelination did not occur in control animals immunized with incomplete Freund's adjuvant and injected with cytokines. These results support the hypothesis that pro-inflammatory molecules produced in the meninges play a major role in cortical demyelination in multiple sclerosis, but also emphasize the involvement of an anti-myelin immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 5×
“…after the acute inflammatory and cytotoxic episode in the current study, in contrast to the substantial neuronal loss in multiple sclerosis cortex (Peterson et al., 2001; Magliozzi et al., 2010), suggests that loss in the multiple sclerosis cortex may occur over a protracted period, possibly…”
BackgroundInfluentialSerafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Self-citationInflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103 · cited 3×
“, 2005), although this may be because these lesions have not been studied during their acute phase, when inflammatory infiltrates have been demonstrated in the parenchyma (Lucchinetti et al., 2011).”
BackgroundInfluentialMeningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Self-citationSubpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 4×
“The pathology is very similar to that reported for cases with SPMS (Bo et al., 2003; Kutzelnigg et al., 2005; Magliozzi et al., 2007; Gilmore et al., 2009), including the lack of peripheral immune cell infiltration.”
BackgroundInfluentialA Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747 · cited 16×
“…and cytotoxic episode in the current study, in contrast to the substantial neuronal loss in multiple sclerosis cortex (Peterson et al., 2001; Magliozzi et al., 2010), suggests that loss in the multiple sclerosis cortex may occur over a protracted period, possibly decades, due to a chronic…”
BackgroundResultInfluentialSelf-citationMeningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386
Disease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311 · cited 1×
“Our findings help to explain why subpial demyelination seems to be specific to multiple sclerosis and was not found in other inflammatory CNS conditions with a meningeal component, such as tuberculous meningoencephalitis or HSV-1 encephalitis (Magliozzi et al., 2010; Frischer et al., 2013).”
BackgroundMerkler, D. (2006) · Brain · doi:10.1093/brain/awl135 · Cited by 222 · cited 5×
“The study of Merkler et al. (2006) suggested that cytokines injected directly into the parenchyma may preferentially drain through subpial areas into the overlying CSF, thereby giving rise to the predominantly subpial distribution of lesions.”
BackgroundMethodResultInfluential
Cited by
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Exploring the origins of grey matter damage in multiple sclerosis
Calabrese, M., Magliozzi, R., Ciccarelli, O., Geurts, J. J. G., Reynolds, R., & Martin, R. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3900 · Cited by 414
Self-citationAdvances in Meningeal Immunity
Rua, R., & McGavern, D. B. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.003 · Cited by 326
“The mechanism allowing immune cells to traffic from the meninges into the parenchyma is unclear, but it is known that inflammatory mediators [reactive oxygen species (ROS), TNF-a, IFN-g] produced in the meninges can potentiate glia limitans breakdown and microglial activation in different inflammatory contexts [7,72,7…”
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Magliozzi, R., Howell, O. W., Nicholas, R., Cruciani, C., Castellaro, M., Romualdi, C., Rossi, S., Pitteri, M., Benedetti, M. D., Gajofatto, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25197 · Cited by 298
Self-citationGlymphatic system impairment in multiple sclerosis: relation with brain damage and disability
Carotenuto, A., Cacciaguerra, L., Pagani, E., Preziosa, P., Filippi, M., & Rocca, M. A. (2022) · Brain · doi:10.1093/brain/awab454 · Cited by 275
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Cencioni, M. T., Mattoscio, M., Magliozzi, R., Bar-Or, A., & Muraro, P. A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00498-5 · Cited by 271
Self-citationCognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights
DeLuca, G. C., Yates, R. L., Beale, H., & Morrow, S. A. (2015) · Brain Pathology · doi:10.1111/bpa.12220 · Cited by 220
“These results point toward a cytotoxic milieu in the meningeal/ CSF compartment, an idea supported by detection of enhanced meningeal gene expression of tumor necrosis factor and interferon-gamma, cytokines known to induce subpial cortical pathology similar to that seen in MS (93).”
ResultTertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
Zhao, L., Jin, S., Wang, S., Zhang, Z., Wang, X., Chen, Z., Wang, X., Huang, S., Zhang, D., & Wu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01947-5 · Cited by 218
Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Bjelobaba, I., Begovic‐Kupresanin, V., Pekovic, S., & Lavrnja, I. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24224 · Cited by 181
“Recently, immunization using MOG/IFA with additionally administered cytokines led to the development of widespread cortical demyelination in both hemispheres (Gardner et al., 2013; Ucal et al., 2017).”
Backgroundvan Olst, L., Rodriguez-Mogeda, C., Picon, C., Kiljan, S., James, R. E., Kamermans, A., van der Pol, S. M. A., Knoop, L., Michailidou, I., Drost, E., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02293-4 · Cited by 87
Self-citationRemyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex
Mezydlo, A., Treiber, N., Ullrich Gavilanes, E. M., Eichenseer, K., Ancău, M., Wens, A., Ares Carral, C., Schifferer, M., Snaidero, N., Misgeld, T., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.031 · Cited by 63
Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models
Zhan, J., Kipp, M., Han, W., & Kaddatz, H. (2021) · Immunology · doi:10.1111/imm.13395 · Cited by 49
Rodriguez, E. G., Wegner, C., Kreutzfeldt, M., Neid, K., Thal, D. R., Jürgens, T., Brück, W., Stadelmann, C., & Merkler, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1260-8 · Cited by 44
Stromal cell niches in the inflamed central nervous system.
Pikor, N. B., Cupovic, J., Onder, L., Gommerman, J. L., & Ludewig, B. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601566 · Cited by 33
“Lastly, administration of the inflammatory Th1 cytokines TNF-a and IFN-g directly into the subarachnoid space of rats preprimed with a CNS Ag is sufficient to induce meningeal TLT-like structures and associated cortical pathology (90).”
BackgroundRemyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Metadata
- Authors
- Gardner, C., Magliozzi, R., Durrenberger, P. F., Howell, O. W., Rundle, J., & Reynolds, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-30
- Volume
- 136
- Issue
- 12
- Pages
- 3596-3608
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2071545791
- Cited by
- 148
- References
- 15
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.